LataMed AI Proposes 5-for-1 Forward Stock Split to Support Expansion in Latin American Telehealth Market

LataMed AI Corp. (OTC: LMED), a digital health and artificial intelligence technology company focused on telehealth infrastructure for emerging markets, announced today that it will formally submit a corporate action request to FINRA seeking approval of a proposed five-for-one forward stock split. The proposal also includes proportional increases in the company’s authorized common and preferred stock.

The corporate action would apply to all issued and outstanding shares of common stock and outstanding preferred stock designations, including the Series C Voting Preferred Stock. The company stated that the forward stock split is intended to support long-term operational scalability, strategic flexibility, and future growth initiatives as LataMed advances telehealth infrastructure deployment, healthcare analytics integration, and commercialization throughout Latin America and other emerging markets.

Management emphasized that the proposed action does not involve debt restructuring, recapitalization, or any reduction in shareholder ownership percentages. No fractional shares are expected to be issued, as any fractional interests would be rounded up to the nearest whole share under the approved Board resolutions.

Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., commented: "As we continue advancing our operational and commercialization initiatives throughout Latin America, we believe this proposed forward stock split and proportional capital structure expansion may support broader long-term strategic flexibility, operational scalability, and future growth initiatives as we continue building our healthcare technology platform."

The company recently commenced initial operational activities for its telehealth platform infrastructure in Venezuela after receiving regulatory authorization from the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloria Sanitaria (SACS). This milestone marks a critical step in LataMed's strategy to deploy digital healthcare solutions in underserved markets.

The proposed forward stock split remains subject to FINRA review and approval, completion of applicable regulatory processing, and final corporate implementation procedures. The company noted that no assurance can be provided regarding the timing or ultimate effectiveness of the proposed action.

LataMed AI Corp. is a development-stage digital health company that has not yet generated revenues from its current business operations. The company is building a technology-enabled healthcare ecosystem designed to support remote patient engagement, provider coordination, and healthcare analytics. Its focus on emerging markets, particularly Latin America, positions it to participate in the ongoing digital transformation of healthcare delivery systems.

For more information, visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.